Autoimmune enteropathy: molecular concepts
Authors:
- Frank M. RuemmeleFRFrank M. Ruemmele
- Nicole BrousseNBNicole Brousse
- Olivier GouletOGOlivier Goulet
- 1 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 20 (6) , 587-591
Abstract
Enteropathies causing temporary or permanent intestinal failure are a big diagnostic and therapeutic challenge for pediatric gastroenterologists. A now well-recognized and distinct entity is in the form of “autoimmune enteropathy (AIE)”. Recent advances in the molecular workup of AIE gave first insight into the pathophysiology of AIE. In this review, we discuss new molecular concepts of AIE resulting in new diagnostic and therapeutic possibilities. The identification of disease-causing mutations in the FOXP3 gene as a basic defect resulting in AIE points to a defect in regulatory T-cell homeostasis. FOXP3, primarily expressed by CD4+CD25+regulatory T cells, is a potent transcriptional suppressor and key modulator of T-cell functions. Nonfunctional FOXP3 leads to a tremendous hyperactivation of T cells, resulting in autoimmune aggression, such as seen in patients with immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked (IPEX) syndrome, a subgroup of AIE. There is recent evidence suggesting that a defect of regulatory factors other than FOXP3 might cause AIE. Anti-enterocyte autoantibodies, another main characteristic of AIE, seem to be of a secondary nature and can no more be considered as directly disease causing. Based on the profound immune dysregulation, new treatment strategies emerged for AIE. The use of T-cell immunosuppressive drugs, such as tacrolimus combined to steroids, seems to be beneficial in some patients; however, long-term remission is not always possible. Bone marrow transplantation might be the treatment of choice in those patients who do not respond to immunosuppression; however, the first encouraging results remain to be confirmed since to date long-term outcome remains mixed.Keywords
This publication has 35 references indexed in Scilit:
- A Long-Term Survivor with the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked SyndromeNew England Journal of Medicine, 2001
- Identification of an autoimmune enteropathy–related 75-kilodalton antigenGastroenterology, 1999
- Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506)Gastroenterology, 1996
- A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathyEuropean Journal of Pediatrics, 1993
- Congenital Diabetes Mellitus and Fatal Secretory Diarrhea in Two InfantsJournal of Pediatric Gastroenterology and Nutrition, 1991
- Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodiesThe Journal of Pediatrics, 1991
- Successful treatment of autoimmune enteropathy with cyclosporineThe Journal of Pediatrics, 1990
- Enteropathy and Renal Involvement in an Infant with Evidence of Widespread Autoimmune DisturbanceJournal of Pediatric Gastroenterology and Nutrition, 1989
- Unresponsive Enteropathy Associated with Circulating Enterocyte Autoantibodies in a Boy with Common Variable Hypogammaglobulinemia and Type I DiabetesJournal of Pediatric Gastroenterology and Nutrition, 1988
- An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancyThe Journal of Pediatrics, 1982